Apr 24, 2020 09:15PM
Apr 24, 2020 07:00AM
Apr 23, 2020 07:00AM
Apr 6, 2020 08:06AM
Apr 6, 2020 08:00AM
Apr 6, 2020 08:00AM
Apr 6, 2020 07:51AM Immunomedics (IMMU) has appointed Harout Semerjian as President and CEO
Apr 6, 2020 07:50AM
Apr 6, 2020 07:50AM
Apr 3, 2020 05:11AM
Apr 1, 2020 01:08PM
Mar 25, 2020 08:03AM
Mar 25, 2020 08:00AM
Mar 25, 2020 08:00AM IMMUNOMEDICS PROVIDES COVID-19 BUSINESS CONTINUITY UPDATE, AFFIRMS 2020 STRATEGIC PRIORITIES, AND SHARES R&D AND REGULATORY UPDATE
Feb 27, 2020 04:39PM
Feb 27, 2020 04:00PM
Feb 27, 2020 04:00PM
Dec 26, 2019 09:16AM
Dec 26, 2019 08:01AM
Dec 26, 2019 08:00AM
Dec 26, 2019 08:00AM Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer
Dec 20, 2018 11:29AM
Nov 13, 2018 01:48PM
Nov 7, 2018 04:05PM
Nov 7, 2018 04:05PM
Aug 23, 2018 04:00PM
Aug 23, 2018 04:00PM
Jul 18, 2018 08:03AM Immunomedics (IMMU) Reports FDA Acceptance of Biologics License Application for Filing and Granted Priority Review for Sacituzumab Govitecan
Jul 18, 2018 08:00AM
Jul 18, 2018 08:00AM

15,422 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All